INTRODUCTION The World Trade Organization (WTO) since its establishment has ratified more than 300 regional and bilateral Free-Trade Agreements (FTA).[i] Recently, the trend of increasing prevalence of TRIPS-Plus provisions within these trade agreements introduces stricter intellectual property (IP) regimes. This…
Counterfeit Medicines India and piracy is a massive global problem that affects practically every industry sector on the planet. India is no different, with widespread counterfeiting, piracy, and smuggling having serious economic, health, and safety ramifications in the country. Small…
3D Printing In Pharmaceutical Industry: The technology and formulation developed to efficiently transport a pharmacologically active molecule in the body in order to achieve therapeutic efficacy in a safe manner is referred to as drug delivery. Controlling the release profile,…
During the period of the Covid-19 pandemic many oppositions were filed beyond the four months period of limitation and the same have also been entertained by the Controller General of Patents, Designs, and Trade Marks (CGPDTM). The Delhi High Court…
Introduction The notion of trade dress is defined in Section 2(zb) of the Trademarks Act 1999, which defines a 'trademark' in broad terms, including shape, packaging, and color combinations, as long as they can be graphically depicted and identify goods…
Patents provide exclusive rights to the patent proprietors over their novel creations. There is an implied expectation that the owners of the patents will work the patented inventions pragmatically on a commercial scale without any undue delay. However, in certain…
After anti-influenza drug Tamiflu (Oseltamivir Phosphate) and antiretroviral drug Viread, Gilead Sciences is again back in news, this time with its hepatitis C (HCV) drug Sofosbuvir. Like Tamiflu and Viread's pre-grant opposition, Sofosbuvir patent application is also facing pre-grant opposition.…
A remarkable latest change in the Patentability has risen from the decision of the Federal Circuit in the case Sun Pharmaceuticals v. Eli Lilly, over the later’s patent that claimed the use of gemcitabine (GEMZAR), a drug to treat cancer.…